Translational Bridge: Autoimmune Disorders Take Center Stage at 'Kshamatvam 2026' International Ayurveda Conference in Udupi
13-Aug-26 11:34:45
As autoimmune diseases—ranging from rheumatoid arthritis and lupus to multiple sclerosis, inflammatory bowel disease, and psoriasis—emerge as some of the most complex, rapidly growing global health challenges, researchers are looking beyond conventional lifelong immunosuppressive care.
To explore how traditional medicine can complement modern biomedical immunology, the Sri Dharmasthala Manjunatheshwara College of Ayurveda, Hospital and Research Centre (SDMAHRC) in Udupi, Karnataka, will host the 6th International Conference on Translational Ayurveda in Autoimmune Disorders, titled "Kshamatvam 2026," from September 29 to October 1, 2026.
The three-day global conference aims to create an evidence-based dialogue bridging ancient Ayurvedic concepts with modern clinical immunology.
Translating Ancient Immunology into Modern Science
The conference centers on "Translational Ayurveda"—an evolving scientific discipline that uses modern research methodologies, clinical trial models, and laboratory testing to evaluate classical traditional principles.
Addressing the media, Dr. Mamatha K. V., Principal of SDMAHRC, highlighted that the event comes at a crucial juncture when rising autoimmune diagnoses worldwide require integrative solutions focused on disease prevention, immune modulation, and patient quality of life.
Key classical Ayurvedic concepts featured in the scientific sessions include:
-
VyÄdhiká¹£amatva: The body's intrinsic host resistance and capacity to prevent or withstand disease progression.
-
Ojas & Bala: Vital immune essences and biological strength that regulate cellular resilience.
-
Agni & Metabolic Health: The role of gut health, digestive fire, and metabolic waste (Ama) in triggering systemic inflammatory reactions.
-
RasÄyana & Panchakarma Therapies: Rejuvenative and detoxifying interventions designed to recalibrate immune hyper-responsiveness.
Global Collaboration: Bringing Together Leading Researchers
Organizers expect between 1,500 and 2,000 delegates, making it one of the largest global academic gatherings dedicated exclusively to Ayurvedic management of autoimmune conditions.
The event features a stellar panel of international and national thought leaders:
-
International Speakers: Dr. Christian Kessler (Germany), Dr. Antonio Morandi (Italy), and Dr. Jorge Luis Berra (Argentina).
-
Indian Academic Leaders: Prof. Bhushan Patwardhan, Dr. Sanjeev Rastogi, and Dr. Rammanohar Puthiyedath.
Pre-conference hands-on workshops scheduled for September 29 will cover specialized practical streams, including Marma Chikitsa in Autoimmune Disorders, OPD-based Panchakarma procedures, drug surveys, and scientific research models.
Elevating Clinical Research and Education
Rather than framing Ayurveda as a mere alternative to modern medicine, Kshamatvam 2026 emphasizes building rigorous, reproducible clinical trial data that enables safe, integrated patient care protocols.
This evidence-driven approach aligns with modern shifts in Ayurveda education, where postgraduate scholars and researchers are increasingly trained in biomedical statistics, clinical pharmacology, and molecular biology alongside classical Samhita studies.
Supported by guidelines from the Ministry of Ayush, such global conferences play a vital role in validating traditional healing models on international scientific platforms.
Stay tuned to our Ayurveda News hub for ongoing coverage, research paper outcomes, and expert insights from Kshamatvam 2026.